Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis ; volume:2 ; number:1 ; day:10 ; month:9 ; year:2013 ; pages:1-5 ; date:12.2013
Systematic Reviews ; 2, Heft 1 (10.9.2013), 1-5, 12.2013
- Creator
-
Tricco, Andrea C.
- Contributor
-
Ashoor, Huda M.
Soobiah, Charlene
Hemmelgarn, Brenda
Moher, David
Hutton, Brian
Yu, Catherine H.
Majumdar, Sumit R.
Straus, Sharon E.
SpringerLink (Online service)
- DOI
-
10.1186/2046-4053-2-73
- URN
-
urn:nbn:de:1111-201607117559
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tricco, Andrea C.
- Ashoor, Huda M.
- Soobiah, Charlene
- Hemmelgarn, Brenda
- Moher, David
- Hutton, Brian
- Yu, Catherine H.
- Majumdar, Sumit R.
- Straus, Sharon E.
- SpringerLink (Online service)
Other Objects (12)
How can we improve the interpretation of systematic reviews?
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
How can we improve the interpretation of systematic reviews?
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
How can we improve the interpretation of systematic reviews?
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison